RMD Open

is an open access, peer-reviewed rheumatology journal that publishes original research on rheumatic and musculoskeletal disorders and connective tissue diseases

Impact Factor: 6.2
Citescore: 7.7
All metrics >>

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

Editorial team

Current Issue

Authors

RMD Open accepts submissions of a wide range of article types, including original research, analysis and practice articles, and commentaries.

The Author Information section provides specific article requirements to help you turn your work into an article suitable for RMD Open.

Information is also provided on editorial policies and open access.

Author information Submit a paper

Latest Articles

Rheumatoid arthritis:

Classification of rheumatoid arthritis: is it time to revise the criteria?

20 April 2024

Epidemiology:

Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology

20 April 2024

Lupus:

Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort

18 April 2024

Psoriatic arthritis:

Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

17 April 2024

Crystal arthropathies:

Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort

16 April 2024

VACANCY: Social Media Editor

RMD Open has an exciting vacancy for an enthusiastic Social Media Editor to join the editorial team. The journal is looking to continue to grow its online visibility and reach across various platforms and the Social Media Editor will play a key role in engaging with the journal’s core audience, sharing the latest research and updates in the field, and interacting with the wider community to help achieve this.

Candidates should be educated to postgraduate level with knowledge and experience of the journal’s subject area. Some experience of science communication and social media would be preferred, but the main criteria for the successful applicant will be enthusiasm for the subject area, creativity, curiosity, and an interest in using digital technologies to disseminate scientific research. The role would be ideally suited to a junior researcher or practising clinician, and they can be based anywhere in the world

Application deadline: 31st May 2024

Find out more and how to apply

Video Abstract

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL

30 January 2024

Conclusions: Bimekizumab demonstrated a safety profile consistent with previous reports; no new safety signals were identified. Sustained efficacy was observed from weeks 16 to 52.

Find out more